Evidence map›Paper›PMID 24920907›Full record

ReviewInternational journal of nanomedicine2014

Multifunctional materials for bone cancer treatment.

Catarina Marques, José M F Ferreira, Ecaterina Andronescu, Denisa Ficai, Maria Sonmez, Anton Ficai

Open access · goldAbstract readReview
In one paragraph

Review in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.International journal of molecular sciences · 2022
    Review
  10. Review
  11. MoSBioactive materials · 2021
    Review
  12. Review
  13. Innovative Biomaterials for the Treatment of Bone Cancer.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Advances in Osteoporotic Bone Tissue Engineering.Journal of clinical medicine · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Catarina MarquesDepartment of Materials and Ceramics Engineering, Centre for Research in Ceramics and Composite Materials, University of Aveiro, Aveiro, Portugal.
José M F FerreiraDepartment of Materials and Ceramics Engineering, Centre for Research in Ceramics and Composite Materials, University of Aveiro, Aveiro, Portugal.
Ecaterina AndronescuFaculty of Applied Chemistry and Material Science, University Politehnica of Bucharest, Bucharest, Romania.
Denisa FicaiFaculty of Applied Chemistry and Material Science, University Politehnica of Bucharest, Bucharest, Romania.
Maria SonmezNational Research and Development Institute for Textiles and Leather, Bucharest, Romania.
Anton FicaiFaculty of Applied Chemistry and Material Science, University Politehnica of Bucharest, Bucharest, Romania.
Universitatea Națională de Știință și Tehnologie Politehnica București · ROUniversity of Aveiro · PTNational Research & Development Institute for Textiles and Leather · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this review is to present the most recent findings in bone tissue engineering. Special attention is given to multifunctional materials based on collagen and collagen-hydroxyapatite composites used for skin and bone cancer treatments. The multi-functionality of these materials was obtained by adding to the base regenerative grafts proper components, such as ferrites (magnetite being the most important representative), cytostatics (cisplatin, carboplatin, vincristine, methotrexate, paclitaxel, doxorubicin), silver nanoparticles, antibiotics (anthracyclines, geldanamycin), and/or analgesics (ibuprofen, fentanyl). The suitability of complex systems for the intended applications was systematically analyzed. The developmental possibilities of multifunctional materials with regenerative and curative roles (antitumoral as well as pain management) in the field of skin and bone cancer treatment are discussed. It is worth mentioning that better materials are likely to be developed by combining conventional and unconventional experimental strategies.

Indexed as

Tissue ScaffoldsAnimalsAntineoplastic AgentsBone NeoplasmsBone SubstitutesCombined Modality TherapyEquipment DesignHumansNanocapsulesAntineoplastic AgentsBone SubstitutesNanocapsulesbone graftcancercollagencytostaticsmagnetitesilver

Identifiers

PMID24920907
PMCPMC4044993
OpenAlexW2035510401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.